Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback